1 not yet recruiting, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Locally Advanced Esophageal Adenocarcinoma: new trials by email Literature Review of Locally Advanced Esophageal Adenocarcinoma trials Research Report on Locally Advanced Esophageal Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Biospecimen Collection, Computed Tomography, Futibatinib - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Phase 1 | Not yet recruiting | Northwestern University | 18 | 2027-09-09 | 2026-10-20 |
| Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma Biopsy, Biospecimen Collection, Computed Tomography - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Phase 2 | Recruiting | Roswell Park Cancer Institute | 40 | 2023-03-07 | 2025-12-16 |
Adenocarcinoma Of Esophagus (2)
Specimen Handling (2) · Biopsy (1) · Fluorouracil (1) · Leucovorin (1) · Magnetic Resonance Spectroscopy (1) · Oxaliplatin (1) · Paclitaxel (1) · Propranolol (1) · Ramucirumab (1) · Taxes (1) · dehydroftorafur (1) · futibatinib (1) · pembrolizumab (1) · propranolol CR (1)
Northwestern University (1) · Roswell Park Cancer Institute (1)
United States (2)
Gladys Rodriguez, MD (1) · Kannan Thanikachalam (1)
P30CA060553 (1)